Cyclosporin-A differentially affects apoptosis during in vivo rat thymocyte maturation

Scandinavian Journal of Immunology

Volumn 56, Issue 4, 2002, Pages 353-360

  Damoiseaux, J G M C ^a   Defresne, M P ^b   Reutelingsperger, C P M ^a   Van Breda Vriesman, P J C ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CYCLOSPORIN A; CYTOKINE; RAPAMYCIN; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD VESSEL; CELL ASSAY; CELL COUNT; CELL INTERACTION; CELL MATURATION; CELL PROLIFERATION; CELL SELECTION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOTHELIUM CELL; IN VIVO STUDY; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; STROMA CELL; THYMOCYTE;

ANIMALS; APOPTOSIS; ATROPHY; CELL DIFFERENTIATION; CLONAL DELETION; CYCLOSPORINE; ENDOTHELIUM, VASCULAR; FEMALE; IMMUNOSUPPRESSIVE AGENTS; MODELS, IMMUNOLOGICAL; RATS; RATS, INBRED LEW; RECEPTOR-CD3 COMPLEX, ANTIGEN, T-CELL; SELF TOLERANCE; SIGNAL TRANSDUCTION; SIROLIMUS; SPECIFIC PATHOGEN-FREE ORGANISMS; T-LYMPHOCYTES; THYMUS GLAND;

EID: 0036381113     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2002.01110.x     Document Type: Article

References (29)

1. Schreiber SL, Crabtree GR. The mechanism of action of cyclosporin A and FK506. Immunol Today 1992;13:136-41.
2. Schreier MH, Baumann G, Zenke G. Inhibition of T-cell signaling pathways by immunophilin drug complexes: are side effects inherent to immunosuppressive properties? Transplant Proc 1993;25:502-7.
3. Abraham RT. Mammalian target of rapamycin: immunosuppressive drugs uncover a novel pathway of cytokine receptor signaling. Curr Opin Immunol 1998;10:330-6.
4. Sehgal SN. Rapamune (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression. Clin Biochem 1998;31:335-40.
5. Gao EK, Lo D, Cheney R et al. Abnormal differentiation of thymocytes in mice treated with Cyclosporin A. Nature 1988;336:176-9.
6. Jenkins MK, Schwartz RH, Pardoll DM. Effects of Cyclosporin A on T cell development and clonal deletion. Science 1988;241:1655-8.
7. Urdahl KB, Pardoll DM, Jenkins MK. Cyclosporin A inhibits positive selection and delays negative selection in αβ TCR transgenic mice. J Immunol 1994;152:2853-9.
8. Homma M, van Breda Vriesman PJC, Damoiseaux JGMC. Defective de novo thymocyte maturation in cyclosporin A-induced autoimmunity: expression of costimulatory and activation molecules. Clin Exp Immunol 1997;110:79-85.
9. Damoiseaux JGMC, Beijleveld LJJ, van Breda Vriesman PJC. The effects of in vivo cyclosporin A administration on rat thymic dendritic cells. Clin Exp Immunol 1994;96:513-20.
10. Beijleveld LJJ, Damoiseaux JGMC, van Breda Vriesman PJC. The differential effects of X-irradiation and Cyclosporin-A administration on the thymus with respect to the generation of Cyclosporin-A induced Autoimmunity. Dev Immunol 1995;4:127-38.
11. Damoiseaux JGMC, Beijleveld LJJ, van Breda Vriesman PJC. Multiple effects of Cyclosporin-A on the thymus in relation to T-cell development and autoimmunity. Clin Immunol Immunopathol 1997;82:197-202.
12. Luo H, Duguid W, Chen H et al. The effect of rapamycin on T cell development in mice. Eur J Immunol 1994;24:692-701.
13. Damoiseaux JGMC, Beijleveld LJJ, Schuurman H-J et al. The effect of in vivo rapamycin treatment on de novo T-cell development in relation to induction of autoimmune-like immunopathology in the rat. Transplantation 1996;62:994-1001.
14. Glazier A, Tutschka PJ, Farmer ER et al. Graft-versus-host disease in cyclosporin A-treated rats after syngeneic and autologous bone marrow reconstitution. J Exp Med 1983;158:1-8.
15. Stuart MCA, Damoiseaux JGMC, Frederik PM et al. Surface exposure of phosphatidylserine during apoptosis of rat thymocytes precedes nuclear changes. Eur J Cell Biol 1998;76:77-83.
16. Dijkstra CD, Döpp EA, Joling P et al. The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology 1985;54:589-99.
17. Surh CD, Sprent. J. T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature 1994;372:100-3.
18. Douek DC, Corley KTT, Zal T et al. Negative selection by endogenous antigen and superantigen occurs at multiple thymic sites. Int Immunol 1996;8:1413-20.
19. Wack A, Ladyman HM, Williams O et al. Direct visualization of thymocyte apoptosis in neglect, acute and steady-state negative selection. Int Immunol 1996;8:1537-48.
20. Milicevic NM, Milicevic Z, Colic M. Macrophages of the rat thymus after cyclosporin treatment: histochemical, enzymehistochemical and immunohistochemical study. Virchows Arch B 1989;57:237-44.
21. Van Ewijk W, Shores EW, Singer A. Crosstalk in the mouse thymus. Immunol Today 1994;15:214-7.
22. Van Ewijk W, Hollander G, Terhorst C et al. Stepwise development of thymic microenvironments in vivo is regulated by thymocyte subsets. Development 2000;127:1583-91.
23. McCarthy SA, Cacchione RN, Mainwaring MS et al. The effects of immunosuppressive drugs on the regulation of activation-induced apoptotic cell death in thymocytes. Transplantation 1992;54:543-7.
24. 1 arrest in exponentially growing T-cell lines. Blood 1998;91:561-9.
25. Tsukiyama T, Ishida N, Shirane M et al. Down-regulation of p27Kip1 expression is required for development and function of T cells. J Immunol 2001;166:304-12.
26. Shortman K, Egerton M, Spangrude GJ et al. The generation and fate of thymocytes. Semin Immunol 1990;2:3-12.
27. Blazar BR, Taylor PA, Snover DC et al. Murine recipients of fully mismatched donor marrow are protected from lethal graft-versus-host disease by the in vivo administration of rapamycin but develop an autoimmune-like syndrome. J Immunol 1993;151:5726-41.
28. Blazar BR, Taylor PA, Panoskaltsis-Mortari A et al. In vivo inhibition of cytokine responsiveness and graft-versus-host disease mortality by rapamycin leads to a clinical-pathological syndrome discrete from that observed with cyclosporin A. Blood 1996;87:4001-9.
29. 1 phase of the cell cycle. J Immunol 2001;166:5611-8.